NexImmune Statistics
Share Statistics
NexImmune has 1.39M
shares outstanding. The number of shares has increased by 1.72%
in one year.
| Shares Outstanding | 1.39M |
| Shares Change (YoY) | 1.72% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 16.85% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 15.99K, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 15.99K |
| Short % of Shares Out | n/a |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 2.26 |
Valuation Ratios
The PE ratio is -0.07 and the forward
PE ratio is -0.03.
NexImmune's PEG ratio is
0.
| PE Ratio | -0.07 |
| Forward PE | -0.03 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/FCF Ratio | -0.07 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NexImmune.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.06 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-5,390,732 |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 2.02, so NexImmune's
price volatility has been higher than the market average.
| Beta | 2.02 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 13.05 |
| Average Volume (20 Days) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.02M |
| Operating Income | -29.19M |
| Net Income | -32.34M |
| EBITDA | -28.17M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -30.82 |
Full Income StatementBalance Sheet
The company has 3.2M in cash and 68.81K in
debt, giving a net cash position of 3.13M.
| Cash & Cash Equivalents | 3.2M |
| Total Debt | 68.81K |
| Net Cash | 3.13M |
| Retained Earnings | -222.59M |
| Total Assets | 5.86M |
| Working Capital | -1.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -31.43M
and capital expenditures -48.72K, giving a free cash flow of -31.48M.
| Operating Cash Flow | -31.43M |
| Capital Expenditures | -48.72K |
| Free Cash Flow | -31.48M |
| FCF Per Share | -30 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
